KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Asset Utilization Ratio (2016 - 2025)

Jazz Pharmaceuticals (JAZZ) has 15 years of Asset Utilization Ratio data on record, last reported at 0.19 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 41.86% year-over-year to 0.19; the TTM value through Dec 2025 reached 0.19, down 41.86%, while the annual FY2025 figure was 0.36, 3.7% up from the prior year.
  • Asset Utilization Ratio reached 0.19 in Q4 2025 per JAZZ's latest filing, up from 0.19 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.37 in Q1 2021 and bottomed at 0.19 in Q3 2025.
  • Average Asset Utilization Ratio over 5 years is 0.29, with a median of 0.34 recorded in 2024.
  • Peak YoY movement for Asset Utilization Ratio: surged 38.09% in 2022, then tumbled 41.86% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.25 in 2021, then surged by 38.09% to 0.34 in 2022, then dropped by 1.61% to 0.34 in 2023, then decreased by 1.18% to 0.34 in 2024, then crashed by 41.86% to 0.19 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.19 in Q4 2025, 0.19 in Q3 2025, and 0.28 in Q2 2025.